Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

[Limb-shaking transitory ischaemic attack in a patient with subocclusion of the internal carotid artery].

Larionov AA, Demin DA, Kulikova EA, Nikolaeva EV, Korzh DA, Gaponov DP, Tarasov DG.

Angiol Sosud Khir. 2018;24(3):152-156. Russian.

PMID:
30321160
2.

Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.

Larionov AA.

Front Oncol. 2018 Apr 3;8:89. doi: 10.3389/fonc.2018.00089. eCollection 2018. Review.

3.

mTOR Regulates Endocytosis and Nutrient Transport in Proximal Tubular Cells.

Grahammer F, Ramakrishnan SK, Rinschen MM, Larionov AA, Syed M, Khatib H, Roerden M, Sass JO, Helmstaedter M, Osenberg D, Kühne L, Kretz O, Wanner N, Jouret F, Benzing T, Artunc F, Huber TB, Theilig F.

J Am Soc Nephrol. 2017 Jan;28(1):230-241. doi: 10.1681/ASN.2015111224. Epub 2016 Jun 13.

4.

Accurate Prediction and Validation of Response to Endocrine Therapy in Breast Cancer.

Turnbull AK, Arthur LM, Renshaw L, Larionov AA, Kay C, Dunbier AK, Thomas JS, Dowsett M, Sims AH, Dixon JM.

J Clin Oncol. 2015 Jul 10;33(20):2270-8. doi: 10.1200/JCO.2014.57.8963. Epub 2015 Jun 1.

5.

Personalization of loco-regional care for primary breast cancer patients (part 2).

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference.

Future Oncol. 2015;11(9):1301-5. doi: 10.2217/fon.15.66.

6.

Personalization of loco-regional care for primary breast cancer patients (part 1).

Toi M, Winer EP, Benson JR, Inamoto T, Forbes JF, von Minckwitz G, Robertson JF, Grobmyer SR, Jatoi I, Sasano H, Kunkler I, Ho AY, Yamauchi C, Chow LW, Huang CS, Han W, Noguchi S, Pegram MD, Yamauchi H, Lee ES, Larionov AA, Bevilacqua JL, Yoshimura M, Sugie T, Yamauchi A, Krop IE, Noh DY, Klimberg VS; 2014 Kyoto Breast Cancer Consensus Conference.

Future Oncol. 2015;11(9):1297-300. doi: 10.2217/fon.15.65.

7.

Molecular changes in lobular breast cancers in response to endocrine therapy.

Arthur LM, Turnbull AK, Webber VL, Larionov AA, Renshaw L, Kay C, Thomas JS, Dixon JM, Sims AH.

Cancer Res. 2014 Oct 1;74(19):5371-6. doi: 10.1158/0008-5472.CAN-14-0620. Epub 2014 Aug 6.

8.

[Retrograde type A aortic dissection after endovascular repair of the thoracic artery].

Gaponov DP, Kavteladze ZA, Gorbunov MG, Chernov II, Tungusov DS, Larionov AA, Korzh DA, Tvorogova AR, Tarasov DG.

Angiol Sosud Khir. 2014;20(1):161-5. Russian.

PMID:
24722035
9.

High prevalence of GPRC5A germline mutations in BRCA1-mutant breast cancer patients.

Sokolenko AP, Bulanova DR, Iyevleva AG, Aleksakhina SN, Preobrazhenskaya EV, Ivantsov AO, Kuligina ESh, Mitiushkina NV, Suspitsin EN, Yanus GA, Zaitseva OA, Yatsuk OS, Togo AV, Kota P, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN.

Int J Cancer. 2014 May 15;134(10):2352-8. doi: 10.1002/ijc.28569. Epub 2014 Jan 27.

10.

Use of microarray analysis to investigate EMT gene signatures.

Sims AH, Larionov AA, Harrison DJ, Katz E.

Methods Mol Biol. 2013;1046:85-95. doi: 10.1007/978-1-62703-538-5_5.

PMID:
23868583
11.

Value of bilateral breast cancer for identification of rare recessive at-risk alleles: evidence for the role of homozygous GEN1 c.2515_2519delAAGTT mutation.

Kuligina ESh, Sokolenko AP, Mitiushkina NV, Abysheva SN, Preobrazhenskaya EV, Gorodnova TV, Yanus GA, Togo AV, Cherdyntseva NV, Bekhtereva SA, Dixon JM, Larionov AA, Kuznetsov SG, Imyanitov EN.

Fam Cancer. 2013 Mar;12(1):129-32. doi: 10.1007/s10689-012-9575-x.

PMID:
23104382
12.

Direct integration of intensity-level data from Affymetrix and Illumina microarrays improves statistical power for robust reanalysis.

Turnbull AK, Kitchen RR, Larionov AA, Renshaw L, Dixon JM, Sims AH.

BMC Med Genomics. 2012 Aug 21;5:35. doi: 10.1186/1755-8794-5-35.

13.

Theory of intercellular communication in the development of endothelial dysfunction.

Inzhutova AI, Larionov AA, Petrova MM, Salmina AB.

Bull Exp Biol Med. 2012 Jun;153(2):201-5. English, Russian.

PMID:
22816083
14.

[Modulation of membrane blebbing and microparticle sheddimg as a target of cardiovascular prophylaxis].

Inzhutova AI, Larionov AA, Lopatina OL.

Vestn Ross Akad Med Nauk. 2011;(11):23-8. Russian.

PMID:
22312904
15.

Understanding the mechanisms of aromatase inhibitor resistance.

Miller WR, Larionov AA.

Breast Cancer Res. 2012 Jan 19;14(1):201. doi: 10.1186/bcr2931. Review.

16.

Bridging the gap between translational research and clinical application.

Miller WR, Larionov AA.

J Natl Cancer Inst Monogr. 2011;2011(43):134-7. doi: 10.1093/jncimonographs/lgr020.

PMID:
22043060
17.

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia.

Sokolenko AP, Iyevleva AG, Preobrazhenskaya EV, Mitiushkina NV, Abysheva SN, Suspitsin EN, Kuligina ESh, Gorodnova TV, Pfeifer W, Togo AV, Turkevich EA, Ivantsov AO, Voskresenskiy DV, Dolmatov GD, Bit-Sava EM, Matsko DE, Semiglazov VF, Fichtner I, Larionov AA, Kuznetsov SG, Antoniou AC, Imyanitov EN.

Int J Cancer. 2012 Jun 15;130(12):2867-73. doi: 10.1002/ijc.26342. Epub 2011 Oct 20.

18.

[Stabilization of cellular membranes as a target of vascular therapy].

Inzhutova AI, Larionov AA, Petrova MM, Salmina AB.

Kardiologiia. 2011;51(4):52-5. Russian.

PMID:
21623721
19.

Challenges in defining predictive markers for response to endocrine therapy in breast cancer.

Larionov AA, Miller WR.

Future Oncol. 2009 Nov;5(9):1415-28. doi: 10.2217/fon.09.113. Review.

PMID:
19903069
20.

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.

Creighton CJ, Li X, Landis M, Dixon JM, Neumeister VM, Sjolund A, Rimm DL, Wong H, Rodriguez A, Herschkowitz JI, Fan C, Zhang X, He X, Pavlick A, Gutierrez MC, Renshaw L, Larionov AA, Faratian D, Hilsenbeck SG, Perou CM, Lewis MT, Rosen JM, Chang JC.

Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13820-5. doi: 10.1073/pnas.0905718106. Epub 2009 Aug 3.

21.

Role of CD38 in cell-cell interactions under conditions of endothelial dysfunction.

Inzhutova AI, Salmina AB, Petrova MM, Larionov AA.

Bull Exp Biol Med. 2008 Jun;145(6):703-6.

PMID:
19110555
22.
23.

Changes in breast cancer transcriptional profiles after treatment with the aromatase inhibitor, letrozole.

Miller WR, Larionov AA, Renshaw L, Anderson TJ, White S, Murray J, Murray E, Hampton G, Walker JR, Ho S, Krause A, Evans DB, Dixon JM.

Pharmacogenet Genomics. 2007 Oct;17(10):813-26.

PMID:
17885619
24.

[One-stage esophagoplasty with gastric tube in patient undergone suturing of esophagus perforation, fundoplication and gastrostomy].

Chernousov AF, Ruchkin DV, Chernousov FA, Larionov AA.

Khirurgiia (Mosk). 2004;(8):62-4. Russian. No abstract available.

PMID:
15446253
25.

[Esophagoplasty with the colon in flap patients with burn strictures of the esophagus].

Chernousov AF, Andrianov VA, Chernookov AI, Chernousov FA, Larionov AA.

Khirurgiia (Mosk). 2003;(7):50-4. Russian.

PMID:
12926340
26.

Aromatase in skeletal muscle.

Larionov AA, Vasyliev DA, Mason JI, Howie AF, Berstein LM, Miller WR.

J Steroid Biochem Mol Biol. 2003 Mar;84(4):485-92.

PMID:
12732294
27.

Local uptake and synthesis of oestrone in normal and malignant postmenopausal breast tissues.

Larionov AA, Berstein LM, Miller WR.

J Steroid Biochem Mol Biol. 2002 May;81(1):57-64.

PMID:
12127042
28.

Aromatase (CYP19) expression in tumor-infiltrating lymphocytes and blood mononuclears.

Berstein LM, Larionov AA, Poroshina TE, Zimarina TS, Leenman EE.

J Cancer Res Clin Oncol. 2002 Mar;128(3):173-6. Epub 2002 Jan 29.

PMID:
11935306
29.

[Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects].

Bershteĭn LM, Maksimov SIa, Gershfel'd ED, Gamaiunova VB, Tsyrlina EV, Meshkova IE, Kovalenko IG, Larionov AA, Kovalevskiĭ AIu, Vasil'ev DA.

Vopr Onkol. 2001;47(5):571-4. Russian.

PMID:
11785098
30.

[Aromatase (estrogen synthetase) gene expression in human leukocytes].

Larionov AA, Poroshina TE, Zimarina TS, Leenman EE, Bershteĭn LM.

Ross Fiziol Zh Im I M Sechenova. 2000 Jan;86(1):10-7. Russian.

PMID:
10740831
31.

[Aromatase gene expression and its modifying factors in breast tumor tissue].

Berstein LM, Larionov AA, Pauley RJ, Chernitsa OI, Semiglazov VF, Yue W, Edamatsu Kh, Ito Kh, Santen R.

Vopr Onkol. 1999;45(5):504-10. Russian.

PMID:
10629706
32.

[Metabolism of the androgenic precursor androstenedione and effects of aromatase inhibitors in cultured blood lymphocytes].

Bershteĭn LM, Poroshina TE, Larionov AA, Zimarina TS.

Ross Fiziol Zh Im I M Sechenova. 1998 Nov;84(11):1242-6. Russian.

PMID:
10204168
33.

[Aromatase activity and its gene expression in tumor tissue of smokers and non-smokers with breast cancer].

Berstein LM, Larionov AA, Chernitsa OI, Kolesnik OS, Manikhas AG.

Vopr Onkol. 1998;44(6):680-2. Russian.

PMID:
10087963
34.

[Distraction osteosynthesis in occlusive diseases of the limb arteries].

Shevtsov VI, Larionov AA, Pepeliaev AG, Petrovskaia NV.

Khirurgiia (Mosk). 1998;(11):17-21. Russian.

PMID:
9864978
35.

Ability of lymphocytes infiltrating breast-cancer tissue to convert androstenedione.

Berstein LM, Poroshina TE, Zimarina TS, Larionov AA, Kovalenko IG, Uporov AV.

Int J Cancer. 1998 Aug 12;77(4):485-7.

36.

[Correlation between tumor tissue aromatase, histological pattern and reproductive status in patients with breast cancer].

Larionov AA, Uporov AV, Semiglazov VF, Berstein LM.

Vopr Onkol. 1998;44(1):37-42. Russian.

PMID:
9578729
37.

[Conversion of androstenedione in the lymphocytes infiltrating the breast tumor tissue].

Bershteĭn LM, Poroshina TE, Zimarina TS, Larionov AA, Uporov AV.

Biull Eksp Biol Med. 1997 Oct;124(10):440-3. Russian. No abstract available.

PMID:
9410179
38.

[Dexamethasone and dibutyryl-cyclic AMP stimulates conversion of androstenedione in human blood lymphocytes].

Bershteĭn LM, Poroshina TE, Larionov AA, Zimarina TS, Kriukova OG.

Dokl Akad Nauk. 1997 Jan;352(2):276-7. Russian. No abstract available.

PMID:
9102103
39.

[Correlation of lymphocytic infiltration of tumor tissue with the hormonal and metabolic state in patients with breast cancer].

Bershteĭn LM, Poroshina TE, Tsyrlina EV, Gamaiunova VB, Kovalenko IG, Iurin AG, Evtushenko TP, Larionov AA, Zimarina TS, Ivanova OA, Semiglazov VF.

Vopr Onkol. 1996;42(5):36-9. Russian.

PMID:
9064900
40.

[Aromatase activity in human muscle tissue].

Bershteĭn LM, Larionov AA, Kriukova OG, Kochnev VA, Semiglazov VF.

Vopr Med Khim. 1996 Jan-Mar;42(1):76-82. Russian.

PMID:
8999663
41.

Aromatase in breast cancer tissue--localization and relationship with reproductive status of patients.

Berstein LM, Larionov AA, Kyshtoobaeva ASh, Pozharisski KM, Semiglazov VF, Ivanova OA.

J Cancer Res Clin Oncol. 1996;122(8):495-8.

PMID:
8698750
42.

[Aromatase activity in breast cancer tissue: the role of a cellular substrate].

Bershteĭn LM, Larionov AA, Kryshtoobaeva ASh, Pozharisskiĭ KM, Semiglazov VF.

Biull Eksp Biol Med. 1995 Oct;120(10):410-3. Russian. No abstract available.

PMID:
8595235
43.

[Androstenedione conversion in human peripheral blood lymphocytes].

Bershteĭn LM, Larionov AA, Kriukova OG.

Biull Eksp Biol Med. 1994 May;117(5):517-9. Russian. No abstract available.

PMID:
9296707
44.

[Adipose and lean body mass in obese pre- and post-menopausal patients with breast cancer: the modifying role of smoking].

Bershteĭn LM, Tsyrlina EV, Semiglazov VF, Larionov AA, Kovalenko IG, Ivanova OA.

Vopr Onkol. 1994;40(7-12):302-9. Russian.

PMID:
7610625
45.

[Changes in the concentration of atrial hormone in hypertensive crises].

Khirmanov VN, Kireenkov IS, Berkovich OA, Larionov AA, Kornilov NV, Vasil'ev OA.

Klin Med (Mosk). 1993;71(3):34-6. Russian.

PMID:
8015212
46.

[Roentgeno-densito-planimetric evaluation of the bones after correction of the defect].

Larionov AA.

Ortop Travmatol Protez. 1991 Apr;(4):28-31. Russian.

PMID:
1754170
47.

[Possibilities of free osteoplasty with distraction osteosynthesis in correction of a defect of the long tubular bone].

Larionov AA, Imerlishvili IA.

Vestn Khir Im I I Grek. 1991 Feb;146(2):74-8. Russian.

PMID:
1652852
48.
49.
50.

Supplemental Content

Loading ...
Support Center